SAN JOSE, Calif.--(BUSINESS WIRE)--Immersion Corporation (NASDAQ:IMMR), the leading developer and licensor of haptics technology, and Simbionix USA Corporation, the world’s leading provider of simulation and training products for medical professionals and the healthcare industry, today announced that the companies have entered into a new license agreement and have successfully settled litigation that was pending in the United States District Court for the Northern District of Ohio. The signing of a non-exclusive, worldwide license agreement for Immersion’s extensive patent portfolio for use in medical training and simulation successfully brings to a close patent infringement litigation that Immersion initiated in April 2008. The settlement resolves outstanding issues; terms are confidential.
